AG
ACOR

Artal Group’s Acorda Therapeutics ACOR Stock Holding History

Artal Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,083
Closed -$8.32M – 92
2015
Q1 		$8.32M Hold
2,083
– – 0.38% 47
2014
Q4 		$10.2M Hold
2,083
– – 0.36% 46
2014
Q3 		$8.47M Sell
2,083
-1,459
-41% -$5.47M 0.31% 48
2014
Q2 		$14.3M Buy
3,542
+625
+21% +$2.55M 0.58% 37
2014
Q1 		$13.3M Sell
2,917
-2,916
-50% -$11.8M 0.48% 46
2013
Q4 		$20.4M Sell
5,833
-3,293
-36% -$12.8M 0.73% 25
2013
Q3 		$37.5M Sell
9,126
-3,374
-27% -$14.5M 1.22% 10
2013
Q2 		$49.5M Buy
+12,500
New +$51.5M 1.56% 6

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artal Group's ACOR Position: Q2 2015 in Review

Artal Group sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 2,083 shares — an estimated $8.32M sold.

Artal Group first reported a position in ACOR in Q2 2013 and held it in 8 quarters. The position peaked at $49.5M in Q2 2013. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • Artal Group reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Artal Group sold 2,083 Acorda Therapeutics shares in Q2 2015, an estimated $8.32M.
  • Artal Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 8 quarters.
  • Artal Group's Acorda Therapeutics position peaked at $49.5M in Q2 2013.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on Artal Group's 13F filing for Q2 2015, filed 13 Aug 2015.